Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis

OBJECTIVE: To establish the non-inferior efficacy of vonoprazan versus lansoprazole in the treatment of Asian patients with erosive oesophagitis (EO). DESIGN: In this phase III, double-blind, multicentre study, patients with endoscopically confirmed EO were randomised 1:1 to receive vonoprazan 20 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Yinglian, Zhang, Shutian, Dai, Ning, Fei, Guijun, Goh, Khean-Lee, Chun, Hoon Jai, Sheu, Bor-Shyang, Chong, Chui Fung, Funao, Nobuo, Zhou, Wen, Chen, Minhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Oesophagus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984055/
https://www.ncbi.nlm.nih.gov/pubmed/31409606
http://dx.doi.org/10.1136/gutjnl-2019-318365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984055/
https://www.ncbi.nlm.nih.gov/pubmed/31409606
http://dx.doi.org/10.1136/gutjnl-2019-318365

Ejemplares similares